6-溴-2-甲基异喹啉-1(2H)-酮 | 864866-92-2

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 6-溴-2-甲基异喹啉-1(2H)-酮
• 英文名称: 6-bromo-2-methylisoquinolin-1(2H)-one
• 英文别名: 6-bromo-2-methylisoquinolin-1-one
• CAS: 864866-92-2
• 化学式: C₁₀H₈BrNO
• 分子量: 238.084
• InChiKey: XWALISSRSGMCSU-UHFFFAOYSA-N

物化性质

• 沸点：
  373.0±42.0 °C(Predicted)
• 密度：
  1.553±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933790090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥环境中保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Bromo-2-methylisoquinolin-1(2h)-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Bromo-2-methylisoquinolin-1(2h)-one
CAS number: 864866-92-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H8BrNO
Molecular weight: 238.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-溴-2-甲基异喹啉-1(2H)-酮 在 bis-triphenylphosphine-palladium(II) chloride 、 N-溴代丁二酰亚胺(NBS) 、 copper(l) iodide 作用下， 以 乙腈 为溶剂， 反应 3.0h， 生成 4-bromo-2-methyl-6-((trimethylsilyl)ethynyl)isoquinolin-1(2H)-one
  参考文献：
  名称：

  Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography

  摘要：

  开发了一种氟-18标记的探针，用于针对癌症的溴域和终端（BET）蛋白进行分子成像，使用正电子发射断层扫描技术。

  DOI：

  10.1039/d2cc04813b
• 作为产物：
  描述：

  6-溴异喹啉 在 caesium carbonate 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 反应 12.0h， 生成 6-溴-2-甲基异喹啉-1(2H)-酮
  参考文献：
  名称：

  面向多种光催化有氧氧化的共价有机框架

  摘要：

  在可见光驱动的有机转化中，光活性二维共价有机骨架（2D-COF）已成为有前途的多相光催化剂。在此，通过使用二维COFs作为光催化剂，开发了可见光驱动的各种有机小分子的选择性好氧氧化。在该方案中，由于2D-COF-1对分子氧活化具有非凡的光催化能力，因此在非常温和的条件下获得了高效，优异的官能团耐受性的各种酰胺，喹诺酮，杂环化合物和亚砜。反应条件。此外，得益于多相光催化的固有优势，突出的可持续性和易于光催化的可回收性，在按比例放大反应中，有选择地轻松获得了一种药物分子（莫达非尼）和一种氧化芥子气模拟物（2-氯乙基乙基亚砜）。使用自由基猝灭实验和原位ESR光谱进行了机理研究，证实了2D-COF-1在光催化循环中的作用。

  DOI：

  10.1002/chem.202100398

文献信息

• THERAPEUTIC COMPOUNDS
  申请人：CELGENE QUANTICEL RESEARCH, INC.

  公开号：US20170298040A1

  公开（公告）日：2017-10-19

  The present disclosure relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of diseases mediated by aberrant cell signalling, such as inflammatory disorders, cancer and neoplastic disease.

  本公开涉及替代杂环衍生治疗化合物，包括所述化合物的组合物，以及通过抑制溴结构域介导的乙酰赖氨酸区域对蛋白质（如组蛋白）的识别来进行表观遗传调控的所述化合物和组合物的用途。所述组合物和方法对于治疗由异常细胞信号传导介导的疾病，如炎症性疾病、癌症和肿瘤性疾病，是有用的。
• [EN] METHODS AND COMPOUNDS FOR TREATING DISORDERS<br/>[FR] PROCÉDÉS ET COMPOSÉS POUR TRAITER DES TROUBLES
  申请人：FOGHORN THERAPEUTICS INC

  公开号：WO2019152440A1

  公开（公告）日：2019-08-08

  The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.

  本发明涉及用于治疗与BAF相关的疾病，如癌症和病毒感染的方法和组合物。
• Deprotonated Salicylaldehyde as Visible Light Photocatalyst
  作者：Yan-Jun Zhuang、Jian-Ping Qu、Yan-Biao Kang

  DOI：10.1021/acs.joc.0c00102

  日期：2020.3.20

  by the deprotonated salicylaldehyde through an energy-transfer pathway. Consequently, the C-C cleaving alkylation reactions of N-hydroxyphthalimide esters proceed smoothly in the presence of as low as 1 mol % of salicylaldehyde under the visible-light irradiation, affording desired alkylation products with up to 99% yields. Application in visible-light induced aerobic oxidation of N-alkylpyridinium

  水杨醛首次被确立为一种有效的可见光光催化剂。与其他简单的醛类似物相比，水杨醛具有从324 nm到417 nm的独特去质子性红移，并导致荧光量子数从0.0368显着增加到0.4632，从而使水杨醛成为可见光（> 400 nm）光催化剂。实验研究表明，反应性自由基是通过去质子化的水杨醛通过能量转移途径使底物敏化而产生的。因此，在低至1mol％的水杨醛存在下，在可见光下，N-羟基邻苯二甲酰亚胺酯的CC裂解烷基化反应顺利进行，以高达99％的产率提供所需的烷基化产物。
• BROMODOMAIN INHIBITORS
  申请人：Quanticel Pharmaceuticals

  公开号：US20150111885A1

  公开（公告）日：2015-04-23

  The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.

  本发明涉及替代杂环衍生物化合物，包括所述化合物的组合物，以及通过抑制溴结构域介导的蛋白质乙酰赖氨酸区域的识别来进行表观遗传调控的所述化合物和组合物的用途。所述组合物和方法对于癌症和肿瘤性疾病的治疗是有用的。
• Carbene-catalyzed aerobic oxidation of isoquinolinium salts: efficient synthesis of isoquinolinones
  作者：Guanjie Wang、Wanyao Hu、Zhouli Hu、Yuxia Zhang、Wei Yao、Lin Li、Zhenqian Fu、Wei Huang

  DOI：10.1039/c8gc01488d

  日期：——

  transformation. This reaction features ambient air as the sole oxidant and oxygen source, a broad substrate scope, and excellent functional-group tolerance and proceeds under mild reaction conditions. Furthermore, a highly efficient synthesis of bioactive molecules and natural products including N-methylcrinasiadine, N-isopentylcrinasiadine, N-phenethylcrinasiadine, isoindolo[2,1-b]isoquinolin-5(7H)-one, PJ-34,

  成功实现了温和环保的卡宾催化的异喹啉鎓盐的好氧氧化。因此，有效地制备了各种异喹啉酮和菲啶酮类，收率良好至优异。机理研究表明，氮杂-布雷斯洛中间体的形成是该转变的关键步骤。该反应具有环境空气作为唯一的氧化剂和氧气源，广泛的底物范围以及出色的官能团耐受性的特点，并且可以在温和的反应条件下进行。此外，生物活性分子和天然产物，包括一种高效合成Ñ -methylcrinasiadine，Ñ -isopentylcrinasiadine，Ñ -phenethylcrinasiadine，异吲哚基[2,1- b完成了] isoquinolin -5（7 H）-1，PJ-34，rac-Gusanlung D，罗塞他星，8-氧代伪巴马汀和伊利福林B的合成。